Sonnet BioTherapeutics (NASDAQ:SONN) stock is taking off on Thursday and investors can thank retail traders on social media for pumping it higher.
SONN stock has been called out by several accounts on Twitter (NYSE:TWTR) as a strong short squeeze target. This has drawn in retail investors looking to pump the stock higher for profits. That movement started this morning with the company leading our pre-market winners.
Before you go investing in SONN stock, I have to point out its penny status. Even with the major gains today, the company is still only trading around $1.76.....More>>>